CRMD's DefenCath, the only FDA-approved antimicrobial catheter lock, saw higher outpatient dialysis use in the fourth quarter ...

Drivers could face up to £1,000 fines and potential prosecution if they fail to report notifiable medical conditions or ...

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases.

CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening ...

Under the leadership of Mr. Todisco, CorMedix has evolved from a single product, development stage company into a multi-product, diversified commercial operation with positive cashflow and a strong ...

A new Indian study warns that the drug-resistant fungus Candida auris is spreading worldwide and becoming deadlier. Led by researchers from Vallabhbhai Patel Chest Institute with support from the ...

The article " Why CorMedix Could be the Biopharma Name to Watch Early in 2026 " first appeared on MarketBeat.

The final, formatted version of the article will be published soon. Background: Tunneled cuffed catheter (TCC) remains a crucial vascular access option for patients undergoing hemodialysis, ...

Entering play Sunday, here’s where every contending team stands with one day remaining in the regular season. After an epic September collapse, all is not lost for the Detroit Tigers. They clinched a ...

Osteosarcoma is a common malignant bone tumor that mostly affects children and adolescents. Its treatment requires a combination of surgery, radiotherapy, and neoadjuvant chemotherapy. As one of the ...